QuidelOrtho Corporation QuidelOrtho Corporation

QuidelOrtho Corporation

QDEL

Rank in Stocks #9938
QuidelOrtho Corporation specializes in the creation and production of... QuidelOrtho Corporation specializes in the creation and production of diagnostic testing solutions, addressing a wide array of healthcare testing demands. The company operates through distinct business units. Its Labs division provides clinical chemistry and immunoassay instruments and tests designed to analyze bodily fluids and proteins, aiding in health assessment, patient management, and tracking disease progression. The Transfusion Medicine unit focuses on ensuring blood safety and compatibility by offering immunohematology and infectious disease screening tests for blood and plasma. For rapid results in various clinical environments, the Point-of-Care segment delivers quick diagnostic tests. Additionally, the Molecular Diagnostics arm develops advanced polymerase chain reaction thermocyclers, analyzers, and amplification systems. QuidelOrtho distributes its offerings both directly to end-users and through an extensive network of distributors. These products are utilized by professionals in settings such as medical offices, hospitals, clinical and reference laboratories, urgent care centers, universities, retail clinics, pharmacies, wellness screening centers, and blood/donor banks, as well as for individual, non-professional, and over-the-counter applications. Founded in 1979 and based in San Diego, California, the company maintains a global footprint, including operations across North America, Europe, the Middle East, Africa, and China.
Share Price
$10.74
Last synced: 2026-11-13
Market Cap
$737.84M
Change (1 day)
1.13%
Change (1 year)
-49.60%
Country

Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this

Category

Healthcare
EPS for QuidelOrtho Corporation (QDEL)
EPS as of September 2026 TTM: $-5.44
According to QuidelOrtho Corporation's latest financial reports, its current EPS (TTM) is $-5.44. At the end of 2025 the company had an EPS of $-16.69, an increase over its 2024 EPS of $-30.54.
EPS history for QuidelOrtho Corporation from 2000 to 2026
EPS at the end of each year
Year EPS Change
2026 (TTM) $-5.44 -67.41%
2025 $-16.69 -45.35%
2024 $-30.54 20,260.00%
2023 $-0.15 -101.55%
2022 $9.66 -42.29%
2021 $16.74 -12.99%
2020 $19.24 980.90%
2019 $1.78 2.30%
2018 $1.74 -825.00%
2017 $-0.24 -42.86%
2016 $-0.42 133.33%
2015 $-0.18 -14.29%
2014 $-0.21 -195.45%
2013 $0.22 46.67%
2012 $0.15 -34.78%
2011 $0.23 -158.97%
2010 $-0.39 -135.45%
2009 $1.10 86.44%
2008 $0.59 37.21%
2007 $0.43 -34.85%
2006 $0.66 -335.71%
2005 $-0.28 40.00%
2004 $-0.20 -129.85%
2003 $0.67 1,575.00%
2002 $0.04 300.00%
2001 $0.01 -104.35%
2000 $-0.23 0.00%
EPS for similar companies or competitors
Company EPS EPS Difference Country
$8.37 -253.86%
US
$5.95 -209.42%
FR
$4.15 -176.29%
US
$5.26 -196.68%
JP
$1.34 -124.63%
CH

Questions about QuidelOrtho Corporation's earnings per share (EPS)

What is QuidelOrtho Corporation's earnings per share (EPS)?

QuidelOrtho Corporation's earnings per share (EPS) over the last twelve months is $-5.44, as of Sep 2026.

What was QuidelOrtho Corporation's earnings per share (EPS) in 2025?

In 2025, QuidelOrtho Corporation's earnings per share (EPS) was $-16.69, compared with $-30.54 in 2024.

How has QuidelOrtho Corporation's earnings per share (EPS) changed since 2020?

From 2020 to 2025, QuidelOrtho Corporation's earnings per share (EPS) was highest in 2020 ($19.24) and lowest in 2024 ($-30.54).

How does QuidelOrtho Corporation's earnings per share (EPS) compare with similar companies?

QuidelOrtho Corporation's earnings per share (EPS) ($-5.44) is lower than that of all 5 similar companies listed above. The highest among them is Intuitive Surgical, Inc., with $8.37.